How AI is redefining clinical collaboration - LinkedIn news interview

An interview with Jay Ackerman, CEO of Reveleer

During a recent LinkedIn Live interview at HLTH 2025 in Las Vegas, our CEO Jay Ackerman sat down with Beth Kutscher, Editor at Large for LinkedIn News, to share his vision for transforming the healthcare landscape through artificial intelligence (AI) and data-driven collaboration. Jay's conversation underscored a critical shift in the healthcare industry away from fragmented data and manual processes to an AI-enabled ecosystem where payers and providers work in sync to deliver measurable value and improved patient outcomes.

‍

‍

‍

Driving transformation through AI and automation

Ackerman opened by highlighting the role Reveleer continues to play in advancing value-based care technology through automation and intelligent data management.

“Reveleer is transforming how payers and providers harness clinical data to drive better decisions and outcomes,” he noted, emphasizing how the company’s AI-powered Evidence Validation Engine (EVE™) analyzes massive datasets with precision to create a full picture of patient care.

By consolidating structured and unstructured data, specifically including clinical notes, test results, and medical histories, Reveleer’s AI-powered software platform enables healthcare organizations to automate complex workflows such as quality improvement, risk adjustment, and clinical validation. This end-to-end automation removes friction from administrative tasks while improving accuracy and accelerating reimbursements.

‍

Enabling collaboration across the care continuum

Ackerman’s discussion went beyond technology. He spoke directly to how AI fosters a more collaborative healthcare ecosystem, one where payers and providers can align on a shared mission: higher quality, more equitable care. He referenced findings from Reveleer’s recent State of Technology in Value-Based Care report, developed in partnership with Mathematica, which revealed that while 90% of organizations see promise in AI, many still struggle with fragmented data strategies and cross-partner coordination.  

Ackerman positioned Reveleer as the bridge to overcome these barriers; a platform that turns raw data into actionable intelligence while empowering organizations to work together more effectively, closing care gaps and driving performance at scale.

‍

Reveleer’s value proposition in action

Reveleer’s AI-driven approach is reimagining what is possible in healthcare operations. From processing 1.1 billion pages of clinical data to validating over 2.5 million diagnoses with 99% accuracy, Reveleer continues to lead the way in scaling efficient value-based care. Its latest platform evolution integrates automation and generative AI to unify data, reduce complexity, and deliver trust and transparency through full source attribution.  

Ackerman’s commentary at the event reaffirmed Reveleer’s commitment to being more than a technology vendor — but a true enablement partner helping healthcare organizations navigate the digital transformation journey with confidence.

For those who missed the live session, you can watch the full Live from HLTH: Recapping the day's news and insights on-demand interview.